142
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

The synthesis and mesomorphic behaviour of tetracatenar and hexacatenar bi‐1,3,4‐oxadiazole derivatives

, , , , , & show all
Pages 7-12 | Received 01 Sep 2008, Accepted 20 Nov 2008, Published online: 19 Feb 2009
 

Abstract

Symmetrical four‐chained (tetracatenar) and six‐chained (hexacatenar) bi‐1,3,4‐oxadiazole ester derivatives, namely 5,5′‐bis[phenyl(3,4‐dialkoxybenzoate)]‐2,2′‐bi‐1,3,4‐oxadiazole (Cn, n = 6, 10, 12, 14, 16) and 5,5′‐bis[phenyl(3,4,5‐trialkoxybenzoate)]‐2,2′‐bi‐1,3,4‐oxadiazole (Dn, n = 7, 10, 14, 16) were synthesised. The liquid crystalline properties were investigated by differential scanning calorimetry, polarised optical microscopy and wide angle X‐ray diffraction. It was revealed that the hexacatenar derivatives (Dn) are non‐mesomorphic, while the tetracatenar ones (Cn) showed a classic progression from smectic C phases (for C6 and C10) to a hexagonal columnar (Colh) phase (for C12, C14 and C16) with the increase in length of the terminal chains. Molecules of Cn (n = 6, 10) tilt about 55‐56° from the layer normal within their SmC phase.

Acknowledgements

The authors are grateful to the National Science Foundation Committee of China (project No. 50373016), Program for New Century Excellent Talents in Universities of China Ministry of Education, Special Foundation for PhD Program in Universities of China Ministry of Education (Project No. 20050183057) and Project 985‐Automotive Engineering of Jilin University for their financial support of this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.